Exacerbation of chronic hepatitis D during interferon alpha administration

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 1, 1999, Pages 66-69

  Crosignani, A ^a   Invernizzi, P ^a   Ferrari, R ^a   Manzin, A ^a   Bruno, S ^a   Zuin, M ^a   Bianchi, F B ^a   Podda, M ^a  

^a Istituto di Scienze Biomediche San Paolo   (Italy)

Author keywords

Adverse events; Basal cell layer antibodies; Chronic hepatitis D; Interferon alpha

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; AUTOANTIBODY; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; ASCITES; BASAL CELL; CASE REPORT; CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HISTOLOGY; HUMAN; JAUNDICE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; RISK;

ADULT; ANTIVIRAL AGENTS; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; INTERFERON-ALPHA; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0032910351     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, et al. Randomized, controlled trial of recombinant human alfa-interferon in patients with chronic hepatitis B. Gastroenterology 1988;95:1318-25.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner BA, et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized double-blind placebo-controlled trial. N Engl J Med 1989;321:1506-10.
3. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12-month course of recombinant human interferon-α in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology 1991;13:1052-6.
4. Farci P, Mandas A, Coiana A, Lai EM, Desmet V, Van Eyken P, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330:88-94.
5. Marzano A, Ottobrelli A, Spezia C, Daziano E, Soranzo ML, Rizzetto M. Treatment of early chronic hepatitis D with lymphoblastoid alpha interferon: a pilot study. Ital J Gastroenterol 1992;24:119-21.
6. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
7. Zauli D, Fusconi M, Crespi C, Bianchi FB, Craxì A, Pisi E. Close association between basal cell layer antibodies and hepatitis B virus-associated chronic delta infection. Hepatology 1984;4:1103-6.
8. Janssen HLA, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxì A, Hadziyannis S. Fatal hepatic decompensation associated with interferon alfa. Br Med J 1993;306:107-8.
9. Marcelin P, Colin JF, Boyer N, Bernuau J, Degott C, Hirschauer C, et al. Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet 1991;338:828.
10. Durand JM, Kaplansky G, Portal I, Scheiner C, Berland Y, Soubeyrand J. Liver failure due to recombinant alpha interferon. Lancet 1991;338:1268-9.
11. Silva MO, Reddy RK, Jeffers LJ, Hill M, Schiff ER. Inteiferon-induced chronic active hepatitis? Gastroenterology 1991;101:840-2.
12. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 1992;102:1406-8.